Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Sees Significant Increase in Short Interest

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 31,081 shares, a growth of 302.9% from the August 15th total of 7,714 shares. Based on an average daily trading volume, of 832 shares, the short-interest ratio is presently 37.4 days.

Wall Street Analyst Weigh In

Separately, Citigroup upgraded Fisher & Paykel Healthcare to a “buy” rating in a research report on Thursday. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

Fisher & Paykel Healthcare Stock Performance

Fisher & Paykel Healthcare stock opened at $25.79 on Friday. Fisher & Paykel Healthcare has a fifty-two week low of $19.01 and a fifty-two week high of $26.53. The firm has a 50 day moving average price of $24.13 and a 200 day moving average price of $23.06.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.